- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
MKPL
NSI
Week ended 07 Aug 2026
Weekly Investor Report
M. K. Proteins Limited · Consumer Defensive · Packaged Foods
Latest close
4.21 INR
0.7%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -15.1% below the Trend Line and sits at 12.3% of its 52-week range. The latest completed week returned 0.7%, after a -8.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal.
Setup score
15
out of 100
Latest Close
4.21 INR
7 Aug 2026
1W Return
0.7%
latest completed week
4W Return
-8.1%
short-term follow-through
12W Return
-17.8%
quarterly tape
Trend Breadth
9.6%
5 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.7%
Latest completed week; four-week move -8.1%.
Indicator stack
5/0
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 33.04%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
54/100
6 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -15.1% below the Trend Line and sits at 12.3% of its 52-week range. The latest completed week returned 0.7%, after a -8.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1012-week average 0.13
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -8.1% over four weeks, -17.8% over 12 weeks, and -37.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year5
Trend breadth9.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.03Latest activity-pressure read.
Pressure change-14476.1%Four-week change in activity pressure.
Leadership-24.59Latest relative-leadership reading.
RS change-25.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength53/100Blend of value, momentum, and quality. Underlying universe rank 48; rank 1 is best.
Value51/100Relative valuation strength. Underlying universe rank 50; rank 1 is best.
Quality50/100Profitability and accounting quality. Underlying universe rank 51; rank 1 is best.
Momentum52/100Medium-term price momentum. Underlying universe rank 49; rank 1 is best.
Growth50/100Revenue and earnings growth. Underlying universe rank 51; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework54/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 23.3x Price divided by trailing earnings.
- Price / sales
- 0.4x Market value relative to trailing revenue.
- EV / EBITDA
- 16.7x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 1.8% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 4.5% Gross profit retained from each unit of revenue.
- Operating margin
- 2.9% Operating profit retained from revenue.
- Free-cash-flow margin
- 0.9% Free cash flow generated from revenue.
- Return on invested capital
- 7.3% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 43.0% Latest one-year revenue growth.
- EPS growth
- -18.7% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 3.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 6 relevant articles.
1 positive · 5 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-52.4%Distance below the 52-week high.
13-week volatility2.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2615 weeks finished lower.
Best week+10.8%Week of 3 Apr.
Worst week-9.8%Week of 27 Mar.
Latest week+0.7%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains7
Flat weeks1
Modest losses10
Sharp losses5
Recent vol2.9%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split16/34Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Consumer Defensive
4-week rank- / 100
Group average-0.4%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD51.0%positive activity pressure
RS44.0%positive relative leadership
Four-week leaders
IndustryIN Packaged Foods
4-week rank44 / 55
Group average-0.9%
Trend breadth43.6%
Trend43.6%active weekly trend signals
MD47.3%positive activity pressure
RS38.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape13/100
Trend, activity pressure, participation, and risk combine to a 13/100 tape read.
Indicator analysis24/100Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.
Activity pressure 0.10; No reversal markers Next-Week ExpectancyNegative 33.04%Next-week expectancy is negative with a 33.04% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors51/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 81; Buyback Yield rank 14 SVQF54/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 730.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 6 relevant articles.
M K Proteins FY26 net profit falls 18.7% to ₹682.90 lakh Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 4.21 INR | 0.7% | 4.96 INR | 10.81 INR | -1.03 | -24.59 | 551.0K | Off |
| 31 Jul 2026 | 4.18 INR | 1.2% | 5.02 INR | 10.95 INR | -0.87 | -25.21 | 422.8K | Off |
| 24 Jul 2026 | 4.13 INR | -7.8% | 5.08 INR | 11.09 INR | -0.54 | -24.90 | 1.0M | Off |
| 17 Jul 2026 | 4.48 INR | -2.2% | 5.14 INR | 11.22 INR | -0.30 | -21.15 | 622.9K | Off |
| 10 Jul 2026 | 4.58 INR | -5.0% | 5.19 INR | 11.35 INR | 0.01 | -19.67 | 1.4M | Off |
| 3 Jul 2026 | 4.82 INR | 0.2% | 5.24 INR | 11.46 INR | 0.12 | -16.37 | 125.1K | Off |
| 26 Jun 2026 | 4.81 INR | -2.0% | 5.28 INR | 11.58 INR | 0.14 | -16.43 | 0 | Off |
| 19 Jun 2026 | 4.91 INR | 3.8% | 5.33 INR | 11.69 INR | 0.23 | -15.17 | 80.5K | Off |
| 12 Jun 2026 | 4.73 INR | -4.1% | 5.38 INR | 11.80 INR | 0.30 | -17.61 | 78.6K | Off |
| 5 Jun 2026 | 4.93 INR | -2.2% | 5.45 INR | 11.89 INR | 0.48 | -13.76 | 80.2K | Off |
| 29 May 2026 | 5.04 INR | 0.0% | 5.50 INR | 12.00 INR | 0.59 | -13.00 | 836.1K | Off |
| 22 May 2026 | 5.04 INR | -1.6% | 5.56 INR | 12.12 INR | 0.65 | -14.11 | 1.3M | Off |
| 15 May 2026 | 5.12 INR | -2.5% | 5.62 INR | 12.25 INR | 0.67 | -12.97 | 1.5M | Off |
| 8 May 2026 | 5.25 INR | -1.1% | 5.67 INR | 12.37 INR | 0.65 | -13.21 | 1.0M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.